Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Datti

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Drug Discovery Today|February 10, 2023
Academic drug discovery in an age of research abundance, and the curious case of chemical screens toward drug repositioningAlessandro Datti
International Journal of Molecular Sciences|March 14, 2026
Curcumin Between Pleiotropic Potential and Translational ConstraintsAlessandro Magini, Alessandro Datti
Journal of Medicinal Chemistry|March 31, 2010
A repurposing strategy identifies novel synergistic inhibitors of Plasmodium falciparum heat shock protein 90Dea Shahinas, Michael Liang, Alessandro Datti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
High-throughput screening identifies cardiac glycosides as potent inhibitors of human tissue kallikrein expression: implications for cancer therapiesIoannis Prassas, Miltiadis Paliouras, Alessandro Datti, et al.
Journal of Biomedicine & Biotechnology|October 21, 2009
MicroRNA implications across neurodevelopment and neuropathologySabata Martino, Ilaria di Girolamo, Antonio Orlacchio, et al.
Breast Cancer Research : BCR|January 20, 2016
Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancerSharon Wang, Jeff C Liu, Danbi Kim, et al.
Life Sciences|July 11, 2018
COX inhibitors and bone: A safer impact on osteoblasts by NO-releasing NSAIDsMaria Cristina Aisa, Alessandro Datti, Antonio Orlacchio, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 16, 2013
High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancerJulia Izrailit, Hal K Berman, Alessandro Datti, et al.
Journal of Biomedicine & Biotechnology|June 9, 2009
Efficient siRNA delivery by the cationic liposome DOTAP in human hematopoietic stem cells differentiating into dendritic cellsSabata Martino, Ilaria di Girolamo, Roberto Tiribuzi, et al.
Expert Opinion on Drug Discovery|October 15, 2024
Targeting AGAT gene expression - a drug screening approach for the treatment of GAMT deficiencyIlona Tkachyova, Michael B Tropak, Alex Lee, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Drug Discovery Today|February 10, 2023
Academic drug discovery in an age of research abundance, and the curious case of chemical screens toward drug repositioningAlessandro Datti
International Journal of Molecular Sciences|March 14, 2026
Curcumin Between Pleiotropic Potential and Translational ConstraintsAlessandro Magini, Alessandro Datti
Journal of Medicinal Chemistry|March 31, 2010
A repurposing strategy identifies novel synergistic inhibitors of Plasmodium falciparum heat shock protein 90Dea Shahinas, Michael Liang, Alessandro Datti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
High-throughput screening identifies cardiac glycosides as potent inhibitors of human tissue kallikrein expression: implications for cancer therapiesIoannis Prassas, Miltiadis Paliouras, Alessandro Datti, et al.
Journal of Biomedicine & Biotechnology|October 21, 2009
MicroRNA implications across neurodevelopment and neuropathologySabata Martino, Ilaria di Girolamo, Antonio Orlacchio, et al.
Breast Cancer Research : BCR|January 20, 2016
Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancerSharon Wang, Jeff C Liu, Danbi Kim, et al.
Life Sciences|July 11, 2018
COX inhibitors and bone: A safer impact on osteoblasts by NO-releasing NSAIDsMaria Cristina Aisa, Alessandro Datti, Antonio Orlacchio, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 16, 2013
High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancerJulia Izrailit, Hal K Berman, Alessandro Datti, et al.
Journal of Biomedicine & Biotechnology|June 9, 2009
Efficient siRNA delivery by the cationic liposome DOTAP in human hematopoietic stem cells differentiating into dendritic cellsSabata Martino, Ilaria di Girolamo, Roberto Tiribuzi, et al.
Expert Opinion on Drug Discovery|October 15, 2024
Targeting AGAT gene expression - a drug screening approach for the treatment of GAMT deficiencyIlona Tkachyova, Michael B Tropak, Alex Lee, et al.
Pageof 9